Berkshire Hathaway Inc
| Profile field | Value |
|---|---|
| Entity type | Firm |
| Stable identity | SEC CIK 0001067983 |
| Normalized activity rows | 7 |
Form 13F is a quarterly snapshot of reportable positions, not the firm's complete balance sheet. It may omit cash, shorts, non-reportable or non-US assets, confidential positions, and wholly owned businesses.
Firm modules state their direction explicitly: Form 13F holdings are BY this firm; Insider Transactions are AT and Analyst Ratings are OF covered underlying issuers from the complete portfolio; News is ABOUT this firm. Officer transactions in the firm's own stock and ratings OF a publicly listed firm remain on its separate issuer page.
Identity cross-reference: 4 conflicts and 13 unmatched current securities. Conflicts are never guessed; candidate tickers remain visible in the component-position ledger.
Prices
The requested portfolio module has no retained observations.
Revenue & Expense
EBITDA exposure attributable to the complete current long-share portfolio. Shares owned multiply each matched issuer's filed per-share fact; options and principal-amount rows are excluded, while unfetched issuer rows remain visible with exact coverage.
Quarterly EBITDA
| Date | Quarterly ebitda exposure |
|---|---|
| 2026-Q2 | -$313.85M |
| 2026-Q1 | $1.21B |
| 2025-Q4 | $1.46B |
| 2025-Q3 | $1.55B |
| 2025-Q2 | -$885.45M |
| 2025-Q1 | $1.43B |
| 2024-Q4 | $1.27B |
| 2024-Q3 | $1.01B |
| 2024-Q2 | $1.22B |
| 2024-Q1 | $1.29B |
| 2023-Q4 | $1.51B |
| 2023-Q3 | $1.12B |
| 2023-Q2 | $1.44B |
| 2023-Q1 | $459.54M |
| 2022-Q4 | $1.39B |
| 2022-Q3 | $1.2B |
| 2022-Q2 | $1.2B |
| 2022-Q1 | $897.05M |
| 2021-Q4 | $1.12B |
| 2021-Q3 | $1.31B |
| 2021-Q2 | $1.23B |
| 2021-Q1 | $731.64M |
| 2020-Q4 | $1.28B |
| 2020-Q3 | $563.73M |
| 2020-Q2 | $629M |
| 2020-Q1 | $1.43B |
| 2019-Q4 | $2.1B |
| 2019-Q3 | $1.81B |
| 2019-Q2 | $1.57B |
| 2019-Q1 | $1.42B |
| 2018-Q4 | -$2.08B |
| 2018-Q3 | $1.68B |
| 2018-Q2 | $1.64B |
| 2018-Q1 | $1.62B |
| 2017-Q4 | $2.08B |
| 2017-Q3 | $943.69M |
| 2017-Q2 | $917.86M |
| 2017-Q1 | $386.39M |
Annual EBITDA
| Date | Annual ebitda exposure |
|---|---|
| 2026 | $4.55B |
| 2025 | $5.71B |
| 2024 | $6.09B |
| 2023 | $5.64B |
| 2022 | $5.19B |
| 2021 | $3.09B |
| 2020 | $7.2B |
| 2019 | $3.31B |
| 2018 | $6.64B |
| 2017 | $3.73B |
Assets & Liabilities
The requested portfolio module has no retained observations.
Price Ratios
The requested portfolio module has no retained observations.
Other
The requested portfolio module has no retained observations.
News
The requested portfolio module has no retained observations.
Included in ETF
The requested portfolio module has no retained observations.
Roast Me
The requested portfolio module has no retained observations.
Firm
The requested portfolio module has no retained observations.
Analyst Ratings
Ratings issued BY analysts employed by this firm; never ratings about the firm.
Unable to fetch a source-backed rating issued by this firm's analysts; zero is not claimed.
Insider Transactions
Loading the complete SEC Form 13F ledger…
Public Company
This tab exists because SEC CIK 0001067983 exactly matches the public issuer registry. It is the sole direction switch: officer trades in the firm's own stock and ratings OF it stay on the issuer page.
Published issuer data.